Common Stock, Par or Stated Value Per Share of Enlivex Therapeutics Ltd. from 31 Dec 2013 to 30 Jun 2025

Taxonomy & unit
us-gaap: ILS/shares and USD/shares
Description
Face amount or stated value per share of common stock.
Summary
Enlivex Therapeutics Ltd. quarterly Common Stock, Par or Stated Value Per Share in ILS/shares history and change rate from 31 Dec 2013 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Common Stock, Par or Stated Value Per Share for the quarter ending 30 Jun 2025 was 0.4.
Enlivex Therapeutics Ltd. quarterly Common Stock, Par or Stated Value Per Share in USD/shares history and change rate from 31 Dec 2013 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Common Stock, Par or Stated Value Per Share for the quarter ending 30 Jun 2024 was 0.4.
Source SEC data
View on sec.gov
Common Stock, Par or Stated Value Per Share, Quarterly (ILS/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Change (%)
Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Common Stock, Par or Stated Value Per Share (ILS/shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 0.4 30 Jun 2025 6-K 29 Aug 2025 2025 Q2
Q4 2024 0.4 0 0% 31 Dec 2024 6-K 29 Aug 2025 2025 Q2
Q4 2023 0.4 0 0% 31 Dec 2023 20-F 30 Apr 2025 2024 FY
Q2 2023 0.4 0 0% 30 Jun 2023 6-K 01 Sep 2023 2023 Q2
Q4 2022 0.4 0 0% 31 Dec 2022 20-F 30 Apr 2024 2023 FY
Q2 2022 0.4 30 Jun 2022 6-K 22 Aug 2022 2022 Q2
Q4 2021 0.4 0 0% 31 Dec 2021 20-F 10 Apr 2023 2022 FY
Q4 2020 0.4 0 0% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q2 2020 0.4 30 Jun 2020 6-K/A 13 Oct 2020 2020 Q2
Q4 2019 0.4 31 Dec 2019 20-F 30 Apr 2021 2020 FY
Q4 2017 0.05 0 0% 31 Dec 2017 20-F 23 Apr 2018 2017 FY
Q4 2016 0.05 +0.04 +400% 31 Dec 2016 20-F 23 Apr 2018 2017 FY
Q4 2015 0.01 0 0% 31 Dec 2015 20-F 24 Feb 2017 2016 FY
Q4 2014 0.01 0 0% 31 Dec 2014 20-F 29 Mar 2016 2015 FY
Q4 2013 0.01 31 Dec 2013 20-F 31 Mar 2015 2014 FY

Enlivex Therapeutics Ltd. Quarterly Common Stock, Par or Stated Value Per Share (USD/shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 0.4 30 Jun 2024 6-K 30 Aug 2024 2024 Q2
Q4 2023 0.4 31 Dec 2023 6-K 30 Aug 2024 2024 Q2
Q2 2021 0.12 +0.01 +9.1% 30 Jun 2021 6-K 06 Aug 2021 2021 Q2
Q4 2020 0.12 +0.01 +9.1% 31 Dec 2020 6-K 06 Aug 2021 2021 Q2
Q2 2020 0.11 30 Jun 2020 6-K/A 13 Oct 2020 2020 Q2
Q1 2020 9 05 Mar 2020 6-K/A 13 Oct 2020 2020 Q2
Q4 2019 0.11 0 0% 31 Dec 2019 20-F 30 Apr 2021 2020 FY
Q4 2018 0.11 0 0% 31 Dec 2018 20-F 30 Apr 2020 2019 FY
Q4 2017 0.11 31 Dec 2017 20-F 30 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.